The DOI matches its Crossref record; 80 of the 82 references it cites were found in a registry or an index.
Cyclin-dependent kinase inhibitor 2B regulates efferocytosis and atherosclerosis
Open accessAbstract
Genetic variation at the chromosome 9p21 risk locus promotes cardiovascular disease; however, it is unclear how or which proteins encoded at this locus contribute to disease.We have previously demonstrated that loss of one candidate gene at this locus, cyclin-dependent kinase inhibitor 2B (Cdkn2b), in mice promotes vascular SMC apoptosis and aneurysm progression.Here, we investigated the role of Cdnk2b in atherogenesis and found that in a mouse model of atherosclerosis, deletion of Cdnk2b promoted advanced development of atherosclerotic plaques composed of large necrotic cores.Furthermore, human carriers of the 9p21 risk allele had reduced expression of CDKN2B in atherosclerotic plaques, which was associated with impaired expression of calreticulin, a ligand required for activation of engulfment receptors on phagocytic cells.As a result of decreased calreticulin, CDKN2B-deficient apoptotic bodies were resistant to efferocytosis and not efficiently cleared by neighboring macrophages.These uncleared SMCs elicited a series of proatherogenic juxtacrine responses associated with increased foam cell formation and inflammatory cytokine elaboration.The addition of exogenous calreticulin reversed defects associated with loss of Cdkn2b and normalized engulfment of Cdkn2bdeficient cells.Together, these data suggest that loss of CDKN2B promotes atherosclerosis by increasing the size and complexity of the lipid-laden necrotic core through impaired efferocytosis. Results Cdkn2b regulates atherosclerotic lesion size and features of plaque vulnerability in vivo.To study the effect of Cdkn2b on atherosclerosis in vivo, we evaluated a total of 114 male and female Cdkn2b -/-,ApoE -/-, Cdkn2b +/-,ApoE -/-, and Cdkn2b +/+ ,ApoE -/-mice that had been fed a high-fat Western diet for 4, 8, or 12 weeks.Total atherosclerotic burden was increased in male Cdkn2b -/-,ApoE -/-animals as soon as 8 weeks after initiating the high-fat diet, as measured by the Authorship note: Tom Quertermous and Nicholas J. Leeper contributed equally to this work.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“cyclin-dependent kinase inhibitor 2B (CDKN2B)-deficient apoptotic cells show decreased expression of calreticulin [149]”
From Immune Clearance of Senescent Cells to Combat Ageing and Chronic Diseases (2020) · cites this paper as [149]
In the citing paper
“Interestingly, atherosclerotic plaques from patients carrying a genetic variation at the 9p21 locus (which includes the CDKN2B gene), which has been associated with atherosclerosis in humans204,205, have reduced levels of calreticulin compared with atherosclerotic plaques from non-carriers203, further supporting a role for defective efferocytosis in cardiovascular disease206.”
From Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities (2019) · cites this paper as [203]
In the citing paper
“For example, Apoe−/− mice with deletion of Cdkn2b had lower levels of calreticulin than control Apoe−/− mice, and Cdkn2b−/−Apoe−/− mice fed a Western diet had increased plaque size and larger necrotic core area than control Apoe−/− mice, which was attributed to intralesional apoptotic cells being resistant to phagocytosis203.”
From Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities (2019) · cites this paper as [203]
In the citing paper
“Thus, apoptotic cells without CDKN2B impair macrophages efferocytosis and result in the development of advanced atherosclerotic plaques with large necrotic cores.”
From Immune Clearance of Senescent Cells to Combat Ageing and Chronic Diseases (2020) · cites this paper as [149]
In the citing paper
“Moreover, supplementation with exogenous calreticulin restores the clearance of CDKN2B-deficient apoptotic cells by macrophages [149].”
From Immune Clearance of Senescent Cells to Combat Ageing and Chronic Diseases (2020) · cites this paper as [149]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Macrophages in the Pathogenesis of Atherosclerosis
Moore, K. J., & Tabas, I. (2011) · Cell · doi:10.1016/j.cell.2011.04.005 · Cited by 2,669
Defining clusters from a hierarchical cluster tree: the Dynamic Tree Cut package for R
Langfelder, P., Zhang, B., & Horvath, S. (2008) · Bioinformatics · doi:10.1093/bioinformatics/btm563 · Cited by 1,892
Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease
Cardiogenics, Schunkert, H., the CARDIoGRAM Consortium, König, I. R., Kathiresan, S., Reilly, M. P., Assimes, T. L., Holm, H., Preuss, M., Stewart, A. F. R., et al. (2011) · Nature Genetics · doi:10.1038/ng.784 · Cited by 1,866
Large-scale association analysis identifies new risk loci for coronary artery disease
The CARDIoGRAMplusC4D Consortium, Deloukas, P., DIAGRAM Consortium, CARDIOGENICS Consortium, MuTHER Consortium, Wellcome Trust Case Control Consortium, Kanoni, S., Willenborg, C., Farrall, M., Assimes, T. L., et al. (2013) · Nature Genetics · doi:10.1038/ng.2480 · Cited by 1,614
A Common Variant on Chromosome 9p21 Affects the Risk of Myocardial Infarction
Helgadottir, A., Thorleifsson, G., Manolescu, A., Gretarsdottir, S., Blondal, T., Jonasdottir, A., Jonasdottir, A., Sigurdsson, A., Baker, A., Palsson, A., et al. (2007) · Science · doi:10.1126/science.1142842 · Cited by 1,594
A Common Allele on Chromosome 9 Associated with Coronary Heart Disease
McPherson, R., Pertsemlidis, A., Kavaslar, N., Stewart, A., Roberts, R., Cox, D. R., Hinds, D. A., Pennacchio, L. A., Tybjaerg-Hansen, A., Folsom, A. R., et al. (2007) · Science · doi:10.1126/science.1142447 · Cited by 1,587
Gardai, S. J., McPhillips, K. A., Frasch, S. C., Janssen, W. J., Starefeldt, A., Murphy-Ullrich, J. E., Bratton, D. L., Oldenborg, P.-A., Michalak, M., & Henson, P. M. (2005) · Cell · doi:10.1016/j.cell.2005.08.032 · Cited by 1,473
Genetic Susceptibility to Death from Coronary Heart Disease in a Study of Twins
Marenberg, M. E., RISCH, N. J., Berkman, L. F., Floderus, B., & Fairé, U. D. (1994) · New England Journal of Medicine · doi:10.1056/nejm199404143301503 · Cited by 1,256
Macrophage death and defective inflammation resolution in atherosclerosis
Tabas, I. (2010) · Nature Reviews Immunology · doi:10.1038/nri2675 · Cited by 1,120
Quantitative assessment of atherosclerotic lesions in mice
Paigen, B. J., Morrow, A., Holmes, P. A., Mitchell, D., & Williams, R. A. (1987) · Atherosclerosis · doi:10.1016/0021-9150(87)90202-4 · Cited by 951
Research works printed but not linked: 1
- Low, 2012, J Vis Exp., e3810
Cited by
Sorted by citations
Chaikof, E. L., Dalman, R. L., Eskandari, M. K., Jackson, B. M., Lee, W. A., Mansour, M., Mastracci, T. M., Mell, M. W., Murad, M. H., Nguyen, L. L., et al. (2017) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2017.10.044 · Cited by 2,848
Vascular smooth muscle cells in atherosclerosis
Bennett, M. R., Sinha, S., & Owens, G. K. (2016) · Circulation Research · doi:10.1161/circresaha.115.306361 · Cited by 2,179
Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities
Bäck, M., Yurdagul, A., Tabas, I., Öörni, K., & Kovanen, P. T. (2019) · Nature Reviews Cardiology · doi:10.1038/s41569-019-0169-2 · Cited by 1,341
CD47-blocking antibodies restore phagocytosis and prevent atherosclerosis
Kojima, Y., Volkmer, J.-P., McKenna, K., Civelek, M., Lusis, A. J., Miller, C. L., Direnzo, D., Nanda, V., Ye, J., Connolly, A. J., et al. (2016) · Nature · doi:10.1038/nature18935 · Cited by 683
Self-citationMonocytes and macrophages in abdominal aortic aneurysm
Raffort, J., Lareyre, F., Clément, M., Hassen‐Khodja, R., Chinetti, G., & Mallat, Z. (2017) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2017.52 · Cited by 431
Therapeutic strategies targeting inflammation and immunity in atherosclerosis: how to proceed?
Engelen, S. E., Robinson, A., Zurke, Y.-X., & Monaco, C. G. (2022) · Nature Reviews Cardiology · doi:10.1038/s41569-021-00668-4 · Cited by 455
Mechanisms and Consequences of Defective Efferocytosis in Atherosclerosis
Yurdagul, A., Doran, A. C., Cai, B., Fredman, G., & Tabas, I. A. (2018) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2017.00086 · Cited by 300
The role of efferocytosis in atherosclerosis
Kojima, Y., Weissman, I. L., & Leeper, N. J. (2017) · Circulation · doi:10.1161/circulationaha.116.025684 · Cited by 289
Self-citationFlores, A. M., Hosseini-Nassab, N., Jarr, K.-U., Ye, J., Zhu, X., Wirka, R. C., Koh, A. L., Tsantilas, P., Wang, Y., Nanda, V., et al. (2020) · Nature Nanotechnology · doi:10.1038/s41565-019-0619-3 · Cited by 289
Self-citationApoptotic vesicles restore liver macrophage homeostasis to counteract type 2 diabetes
Zheng, C., Sui, B., Zhang, X., Hu, J., Chen, J., Liu, J., Wu, D., Ye, Q., Xiang, L., Qiu, X., et al. (2021) · Journal of Extracellular Vesicles · doi:10.1002/jev2.12109 · Cited by 219
Genetics of Common, Complex Coronary Artery Disease
Musunuru, K., & Kathiresan, S. (2019) · Cell · doi:10.1016/j.cell.2019.02.015 · Cited by 246
Atherosclerosis – A matter of unresolved inflammation
Viola, J. R., & Soehnlein, O. (2015) · Seminars in Immunology · doi:10.1016/j.smim.2015.03.013 · Cited by 229
Macrophage Trafficking, Inflammatory Resolution, and Genomics in Atherosclerosis
Moore, K. J., Koplev, S., Fisher, E. A. A., Tabas, I. A., Björkegren, J., Doran, A. C., & Kovacic, J. C. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.08.2147 · Cited by 229
Immune Clearance of Senescent Cells to Combat Ageing and Chronic Diseases
Song, P., An, J., & Zou, M.-H. (2020) · Cells · doi:10.3390/cells9030671 · Cited by 198
Stroke genetics: discovery, biology, and clinical applications
Dichgans, M., Pulit, S. L., & Rosand, J. M. (2019) · The Lancet Neurology · doi:10.1016/s1474-4422(19)30043-2 · Cited by 187
Inflammation Resolution: Implications for Atherosclerosis
Doran, A. C. (2022) · Circulation Research · doi:10.1161/circresaha.121.319822 · Cited by 181
Vascular Macrophages in Atherosclerosis
Xu, H., Jiang, J., Chen, W., Li, W., & Chen, Z. (2019) · Journal of Immunology Research · doi:10.1155/2019/4354786 · Cited by 176
Efferocytosis in atherosclerosis
Adkar, S. S., & Leeper, N. J. (2024) · Nature Reviews Cardiology · doi:10.1038/s41569-024-01037-7 · Cited by 182
Self-citationThe role of T and B cells in human atherosclerosis and atherothrombosis
Ammirati, E., Moroni, F., Magnoni, M., & Camici, P. G. (2014) · Clinical & Experimental Immunology · doi:10.1111/cei.12477 · Cited by 160
Nanoparticle Therapy for Vascular Diseases
Flores, A. M., Ye, J., Jarr, K.-U., Hosseini-Nassab, N., Smith, B. R., & Leeper, N. J. (2019) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.118.311569 · Cited by 155
Self-citationGene expression signatures, pathways and networks in carotid atherosclerosis
Matic, L. P., Aldi, S., Sun, Y., Folkersen, L., Razuvaev, A., Roy, J., Lengquist, M., Åkesson, S., Wheelock, C. E., Mäegdefessel, L., et al. (2015) · Journal of Internal Medicine · doi:10.1111/joim.12448 · Cited by 145
Self-citationIntegrative functional genomics identifies regulatory mechanisms at coronary artery disease loci
Miller, C. L., Pjanic, M., Wang, T., Nguyen, T., Cohain, A. T., Lee, J. D., Matic, L. P., Hedin, U., Kundu, R. K., Majmudar, D., et al. (2016) · Nature Communications · doi:10.1038/ncomms12092 · Cited by 141
Self-citationEfferocytosis in atherosclerotic lesions: Malfunctioning regulatory pathways and control mechanisms
Tajbakhsh, A., Rezaee, M., Kovanen, P. T., & Sahebkar, A. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.02.003 · Cited by 134
Wang, Y., Nanda, V., Direnzo, D., Ye, J.-Q., Xiao, S., Kojima, Y., Howe, K., Jarr, K., Flores, A. M., Tsantilas, P., et al. (2020) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.2006348117 · Cited by 116
Self-citationGonzález, L., & Trigatti, B. L. (2016) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2016.12.010 · Cited by 136
Yang, M. H., Liu, J., Piao, C., Shao, J., & Du, J. (2015) · Cell Death and Disease · doi:10.1038/cddis.2015.144 · Cited by 130
The Role of Lipids and Lipoproteins in Atherosclerosis
Linton, M. F., Yancey, P. G., Davies, S. S., Jerome, W. G., Linton, E. F., Song, W., Doran, A. C., & Vickers, K. C. (2015) · Europe PMC (PubMed Central) · Cited by 108
Holdt, L. M., & Teupser, D. (2018) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2018.00145 · Cited by 108
Senescent cells and macrophages: key players for regeneration?
Elder, S. S., & Emmerson, E. (2020) · Open Biology · doi:10.1098/rsob.200309 · Cited by 114
Mueller, P. A., Zhu, L., Tavori, H., Huynh, K. T., Giunzioni, I., Stafford, J. M., Linton, M. F., & Fazio, S. (2018) · Circulation · doi:10.1161/circulationaha.117.031702 · Cited by 103
Nagao, M., Lyu, Q., Zhao, Q., Wirka, R. C., Bagga, J. S., Nguyen, T., Cheng, P. P., Kim, J. B., Pjanic, M., Miano, J. M., et al. (2019) · Circulation Research · doi:10.1161/circresaha.119.315968 · Cited by 99
Self-citationThe Genetic Basis of Peripheral Arterial Disease
Kullo, I. J., & Leeper, N. J. (2015) · Circulation Research · doi:10.1161/circresaha.116.303518 · Cited by 91
Self-citationThe ABCA1-efferocytosis axis: A new strategy to protect against atherosclerosis
Chen, W., Li, L., Wang, J., Zhang, R., Zhang, T., Wu, Y., Wang, S., & Xing, D. (2021) · Clinica Chimica Acta · doi:10.1016/j.cca.2021.02.025 · Cited by 84
The mineralocorticoid receptor as a modulator of innate immunity and atherosclerosis
van der Heijden, C. D. C. C., Deinum, J., Joosten, L. A. B., Netea, M. G., & Riksen, N. P. (2018) · Cardiovascular Research · doi:10.1093/cvr/cvy092 · Cited by 79
Targeting senescent cells to attenuate cardiovascular disease progression
Song, P., Zhao, Q., & Zou, M. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101072 · Cited by 81
Complex genetics of female fertility
Gajbhiye, R., Fung, J. N., & Montgomery, G. W. (2018) · npj Genomic Medicine · doi:10.1038/s41525-018-0068-1 · Cited by 69
Eating the dead to keep atherosclerosis at bay
Brophy, M. L., Dong, Y., Wu, H., Rahman, H. N. A., Song, K., & Chen, H. (2017) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2017.00002 · Cited by 68
Ou, M., Li, X., Zhao, S., Cui, S., & Tu, J. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.102694 · Cited by 67
RetractedThe Dual Role of Low-Density Lipoprotein Receptor-Related Protein 1 in Atherosclerosis
Chen, J., Su, Y., Pi, S., Hu, B., & Mao, L. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.682389 · Cited by 70
Rayner, K. J. (2017) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.117.309229 · Cited by 68
Zhang, S., Yeap, X., DeBerge, M., Naresh, N. K., Wang, K., Jiang, Z., Wilcox, J. E., White, S. M., Morrow, J., Burridge, P. W., et al. (2017) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2017.03.013 · Cited by 64
Potential Mechanisms and Effects of Efferocytosis in Atherosclerosis
Wang, L., Li, H., Tang, Y., & Yao, P. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.585285 · Cited by 67
Li, Y., To, K., Kanellakis, P., Hosseini, H., Deswaerte, V., Tipping, P. G., Smyth, M. J., Toh, B., Bobik, A., & Kyaw, T. S. (2014) · Circulation Research · doi:10.1161/circresaha.116.304734 · Cited by 62
CDKN2B Regulates TGF β Signaling and Smooth Muscle Cell Investment of Hypoxic Neovessels
Nanda, V., Downing, K. P., Ye, J., Xiao, S., Kojima, Y., Spin, J. M., DiRenzo, D. M., Nead, K. T., Connolly, A. J., Dandona, S., et al. (2015) · Circulation Research · doi:10.1161/circresaha.115.307906 · Cited by 60
Self-citationIyer, D., Zhao, Q., Wirka, R. C., Naravane, A. V., Nguyen, T., Liu, B., Nagao, M., Cheng, P. P., Miller, C. L., Kim, J. B., et al. (2018) · PLoS Genetics · doi:10.1371/journal.pgen.1007681 · Cited by 60
Self-citationChen, L., Qu, H., Guo, M. H., Zhang, Y., Cui, Y., Yang, Q., Bai, R., & Shi, D. (2019) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/jcpt.13060 · Cited by 59
MicroRNA Regulation of Vascular Smooth Muscle Function and Phenotype
Mäegdefessel, L., Rayner, K. J., & Leeper, N. J. (2014) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.114.304877 · Cited by 57
Self-citationDeficiency of macrophage PHACTR1 impairs efferocytosis and promotes atherosclerotic plaque necrosis
Kasikara, C., Schilperoort, M., Gerlach, B. D., Xue, C., Wang, X., Zheng, Z., Kuriakose, G., Dorweiler, B., Zhang, H., Fredman, G., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci145275 · Cited by 52
Shen, Z., Chen, X.-Q., Sun, X., Sun, J., Zhang, W., Zheng, X., Zhang, Y.-Y., Shi, H., Zhang, J., Li, C., et al. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.739243 · Cited by 50
Tajbakhsh, A., Hayat, S. M. G., Butler, A. E., & Sahebkar, A. (2019) · Ageing Research Reviews · doi:10.1016/j.arr.2019.01.007 · Cited by 49
Ligand-dependent kinase activity of MERTK drives efferocytosis in human iPSC-derived macrophages
Wanke, F., Gutbier, S., Rümmelin, A., Steinberg, M., Hughes, L. D., Koenen, M., Komuczki, J., Regan-Komito, D., Wagage, S., Hesselmann, J., et al. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03770-0 · Cited by 49
Functional regulatory mechanism of smooth muscle cell-restricted LMOD1 coronary artery disease locus
Nanda, V., Wang, T., Pjanic, M., Liu, B., Nguyen, T., Matic, L. P., Hedin, U., Koplev, S., Ma, L., Franzén, O., et al. (2018) · PLoS Genetics · doi:10.1371/journal.pgen.1007755 · Cited by 47
Self-citationYang, J., Gu, L., Guo, X., Huang, J., Chen, Z., Huang, G., Kang, Y., Zhang, X., Long, J., & Su, L. (2018) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-018-0593-6 · Cited by 47
Current status and strategies of long noncoding RNA research for diabetic cardiomyopathy
Pant, T., Dhanasekaran, A., Fang, J., Bai, X., Bosnjak, Z. J., Liang, M., & Ge, Z. (2018) · BMC Cardiovascular Disorders · doi:10.1186/s12872-018-0939-5 · Cited by 45
DiRenzo, D. M., Owens, G. K., & Leeper, N. J. (2017) · Circulation Research · doi:10.1161/circresaha.116.310091 · Cited by 44
Self-citationEfferocytosis and Its Associated Cytokines: A Light on Non-tumor and Tumor Diseases?
Lin, D., Kang, X., Shen, L. H., Tu, S., Lenahan, C., Chen, Y., Wang, X., & Shao, A. (2020) · Molecular Therapy — Oncolytics · doi:10.1016/j.omto.2020.04.010 · Cited by 48
Metabolic Consequences of Efferocytosis and Its Impact on Atherosclerosis
Yurdagul, A. (2021) · Immunometabolism · doi:10.20900/immunometab20210017 · Cited by 41
Yang, B., Hang, S., Xu, S., Gao, Y., Yu, W., Zang, G., Zhang, L., & Wang, Z. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e32073 · Cited by 46
An update on ox-LDL-inducing vascular smooth muscle cell-derived foam cells in atherosclerosis
Guo, J., & Du, L. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1481505 · Cited by 44
Genetics and Genomics of Coronary Artery Disease
Pjanic, M., Miller, C. L., Wirka, R. C., Kim, J. B., DiRenzo, D. M., & Quertermous, T. (2016) · Current Cardiology Reports · doi:10.1007/s11886-016-0777-y · Cited by 40
Self-citationDhawan, U. K., Singhal, A., & Subramanian, M. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105699 · Cited by 41
Mueller, P. A., Kojima, Y., Huynh, K. T., Maldonado, R. A., Ye, J., Tavori, H., Pamir, N., Leeper, N. J., & Fazio, S. (2021) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.121.316854 · Cited by 40
Self-citationNanoparticle-Based Approaches towards the Treatment of Atherosclerosis
Prilepskii, A. Y., Serov, N., Kladko, D. V., & Vinogradov, V. V. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12111056 · Cited by 38
Efferocytosis in multisystem diseases (Review)
Zhang, Y., Wang, Y., Ding, J., & Liu, P. (2021) · Molecular Medicine Reports · doi:10.3892/mmr.2021.12529 · Cited by 38
Genetic Insights Into Smooth Muscle Cell Contributions to Coronary Artery Disease
Wong, D., Turner, A. W., & Miller, C. L. (2019) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.119.312141 · Cited by 36
Self-citationRecent advances in therapeutic targeting of inflammation in atherosclerosis
Hedin, U., & Matic, L. P. (2018) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2018.10.051 · Cited by 37
Self-citationThe role of the mineralocorticoid receptor in immune cells in cardiovascular disease
van der Heijden, C. D. C. C., Bode, M., Riksen, N. P., & Wenzel, U. O. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15782 · Cited by 36
Macrophage: A Key Therapeutic Target in Atherosclerosis?
Taghizadeh, E., Taheri, F., Renani, P. G., Reiner, Ž., Navashenaq, J. G., & Sahebkar, A. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666190830153056 · Cited by 34
Sex-dependent differences in the secretome of human endothelial cells
Cattaneo, M. G., Banfi, C., Brioschi, M., Lattuada, D., & Vicentini, L. M. (2021) · Biology of Sex Differences · doi:10.1186/s13293-020-00350-3 · Cited by 35
Mehramiz, M., Ghasemi, F., Esmaily, H., Tayefi, M., Hassanian, S. M., Sadeghzade, M., Sadabadi, F., Moohebati, M., Azarpazhooh, M. R., Parizadeh, S. M. R., et al. (2016) · Clinical Nutrition · doi:10.1016/j.clnu.2016.12.018 · Cited by 33
Loss of CDKN2B Promotes Fibrosis via Increased Fibroblast Differentiation Rather Than Proliferation
Scruggs, A. M., Koh, H. B., Tripathi, P., Leeper, N. J., White, E. S., & Huang, S. K. (2018) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2017-0298oc · Cited by 33
Self-citationTranslating GWAS Findings to Novel Therapeutic Targets for Coronary Artery Disease
Shu, L., Blencowe, M., & Yang, X. (2018) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2018.00056 · Cited by 31
Efferocytosis of vascular cells in cardiovascular disease
Cabrera, J. T. O., & Makino, A. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107919 · Cited by 32
The Role of Necroptosis in Atherosclerotic Disease
Leeper, N. J. (2016) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2016.08.002 · Cited by 31
Self-citationOmics Approaches Unveiling the Biology of Human Atherosclerotic Plaques
Wu, X., & Zhang, H. (2024) · American Journal Of Pathology · doi:10.1016/j.ajpath.2023.12.007 · Cited by 26
Gomez, D. A., & Owens, G. K. (2016) · Circulation Research · doi:10.1161/circresaha.116.310104 · Cited by 28
Rykaczewska, U., Zhao, Q., Saliba‐Gustafsson, P., Lengquist, M., Kronqvist, M., Bergman, O., Huang, Z., Lund, K., Wadén, K., Pons, Z., et al. (2022) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.121.317018 · Cited by 26
Self-citationPhytochemical-mediated efferocytosis and autophagy in inflammation control
Vafadar, A., Tajbakhsh, A., Hosseinpour-Soleimani, F., Savardshtaki, A., & Hashempur, M. H. (2024) · Cell Death Discovery · doi:10.1038/s41420-024-02254-2 · Cited by 27
Lin, J. J., & Musunuru, K. (2018) · Circulation Genomic and Precision Medicine · doi:10.1161/circgen.117.001946 · Cited by 27
Aarabi, G., Zeller, T., Heydecke, G., Munz, M., Schäfer, A. S., & Seedorf, U. (2018) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2018.00047 · Cited by 26
Liang, S., Sun, Q., Du, Z., Ren, X., Xu, Q., Sun, Z., & Duan, J. (2022) · Nanotoxicology · doi:10.1080/17435390.2022.2083995 · Cited by 24
Svensson, P., Wahlstrand, B., Olsson, M. M., Froguel, P., Falchi, M., Bergman, R. N., McTernan, P. G., Hedner, T., Carlsson, L. M. S., & Jacobson, P. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.03.075 · Cited by 28
MRTF-A regulates proliferation and survival properties of pro-atherogenic macrophages
An, J., Naruse, T. K., Hinohara, K., Soejima, Y., Sawabe, M., Nakagawa, Y., Kuwahara, K., & Kimura, A. (2019) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2019.05.015 · Cited by 23
Cellular mechanisms underlying the impairment of macrophage efferocytosis
Ma, Y., Kemp, S. S., Yang, X., Wu, M. H., & Yuan, S. Y. (2023) · Immunology Letters · doi:10.1016/j.imlet.2023.02.001 · Cited by 22
Can Inflammation-Resolution Provide Clues to Treat Patients According to Their Plaque Phenotype?
Fredman, G. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00205 · Cited by 22
Macrophage efferocytosis in atherosclerosis
Baraniecki, Ł., Tokarz–Deptuła, B., Syrenicz, A., & Deptuła, W. (2022) · Scandinavian Journal of Immunology · doi:10.1111/sji.13251 · Cited by 21
Tabas, I. A. (2016) · Nature · doi:10.1038/nature18916 · Cited by 24
Functional Assays to Screen and Dissect Genomic Hits
Musunuru, K., Bernstein, D., Cole, F. S., Khokha, M. K., Lee, F. S., Lin, S., McDonald, T. V., Moskowitz, I. P. G., Quertermous, T., Sankaran, V. G., et al. (2018) · Circulation Genomic and Precision Medicine · doi:10.1161/circgen.118.002178 · Cited by 20
Self-citationJarr, K.-U., Kojima, Y., Weissman, I. L., & Leeper, N. J. (2022) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.122.317049 · Cited by 21
Self-citationAutophagy in Atherosclerotic Plaque Cells: Targeting NLRP3 Inflammasome for Self-Rescue
Li, X., Zhu, X., & Wei, Y. (2022) · Biomolecules · doi:10.3390/biom13010015 · Cited by 20
Calreticulin Regulates Neointima Formation and Collagen Deposition following Carotid Artery Ligation
Zimmerman, K. A., Xing, D., Pallero, M. A., Lu, A., Ikawa, M., Black, L. L., Hoyt, K., Kabarowski, J. H. S., Michalak, M., & Murphy-Ullrich, J. E. (2015) · Journal of Vascular Research · doi:10.1159/000443884 · Cited by 18
Genetic Analysis for Coronary Artery Disease Toward Diverse Populations
Miyazawa, K., & Ito, K. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.766485 · Cited by 20
Khan, S. U., Saeed, S., Alsuhaibani, A. M., Fatima, S., Rehman, K. U., Zaman, U., Ullah, M., Refat, M. S. E.-D., & Lu, K. (2023) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2023.101821 · Cited by 19
Girelli, D., Piubelli, C., Martinelli, N., Corrocher, R., & Olivieri, O. (2017) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2017.03.019 · Cited by 18
Anandan, V., Thulaseedharan, T., Suresh Kumar, A., Chandran Latha, K., Revikumar, A., Mullasari, A., Kartha, C. C., Jaleel, A., & Ramachandran, S. (2021) · Cells · doi:10.3390/cells10123598 · Cited by 18
Cao, C., Liu, W., Guo, X., Weng, S., Chen, Y., Luo, Y., Wang, S., Zhu, B., Liu, Y., & Peng, D. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1460431 · Cited by 16
Defective efferocytosis of vascular cells in heart disease
Singh, B., Li, K. S., Cui, K., Peng, Q., Cowan, D. B., Wang, D., Chen, K., & Chen, H. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.1031293 · Cited by 18
Macrophage Anti-inflammatory Behaviour in a Multiphase Model of Atherosclerotic Plaque Development
Ahmed, I. U., Byrne, H. M., & Myerscough, M. R. (2023) · Bulletin of Mathematical Biology · doi:10.1007/s11538-023-01142-7 · Cited by 16
You, P., Yang, A., Sun, Y., Zhang, H., Zeng, Y., Hao, Y., Xiong, J., Ma, S., Zhang, H., Liu, B., et al. (2023) · Materials & Design · doi:10.1016/j.matdes.2023.112316 · Cited by 16
Human Genetics of Atherothrombotic Disease and its Risk Factors
Rader, D. J. (2015) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.115.305492 · Cited by 14
Metadata
- Authors
- Kojima, Y., Downing, K., Kundu, R., Miller, C., Dewey, F., Lancero, H., Raaz, U., Perisic, L., Hedin, U., Schadt, E., Maegdefessel, L., Quertermous, T., & Leeper, N. J.
- Affiliations
- Stanford Medicine (US)
- Karolinska Institutet (SE)
- Icahn School of Medicine at Mount Sinai (US)
- Corresponding author
- Leeper, Nicholas J.
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2014-02-17
- Volume
- 124
- Issue
- 3
- Pages
- 1083-1097
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC3938254
- OpenAlex
- W2110153407
- Cited by
- 148
- References
- 82
- Citations by year
- 2026: 4 · 2025: 7 · 2024: 12 · 2023: 12 · 2022: 11 · 2021: 17 · 2020: 13 · 2019: 14 · 2018: 18 · 2017: 13 · 2016: 15 · 2015: 8 · 2014: 4
- FWCI
- 6.09
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Heart Association (10BGIA3290011)
- Gilead Sciences
- Fondation Leducq
- National Institutes of Health
- National Heart, Lung, and Blood Institute (R01HL103635, K08HL103605, R01HL109512, T32HL007544, T32HL098049, T32HL094274)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Life Sciences › Immunology and Microbiology › Immunology › Phagocytosis and Immune Regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Keywords
- CDKN2B, atherosclerosis, efferocytosis, calreticulin, engulfment receptor, macrophage phagocytosis, apoptotic bodies, necrotic core, foam cell formation, vascular smooth muscle cell apoptosis, plaque vulnerability, juxtacrine signaling, inflammatory cytokines, ApoE-deficient mice
- MeSH terms
- Animals, Carotid Arteries, Cells, Cultured, Coronary Vessels, Female, Humans, Macrophages, Male, Mice, Inbred C57BL, Necrosis, Phagocytosis, Down-Regulation, Gene Expression, Retinoblastoma Protein, Apoptosis, Mice, Knockout, Coculture Techniques, Myocytes, Smooth Muscle, Calreticulin, Quantitative Trait Loci, Atherosclerosis, E2F4 Transcription Factor, Cyclin-Dependent Kinase Inhibitor p15, Mice, Plaque, Atherosclerotic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
